Ubs Group Ag Gilead Sciences, Inc. Put Options Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

Put Options

31 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$66.59 - $83.99 $11.1 Million - $14 Million	166,300 Added 31.28%	698,000 $58.5 Million
Q2 2024 Aug 13, 2024	SELL	$63.15 - $72.88 $5.61 Million - $6.47 Million	-88,800 Reduced 14.31%	531,700 $36.5 Million
Q1 2024 May 13, 2024	SELL	$71.58 - $87.29 $48.6 Million - $59.2 Million	-678,600 Reduced 52.24%	620,500 $45.5 Million
Q4 2023 Feb 09, 2024	BUY	$73.27 - $83.09 $2.34 Million - $2.66 Million	32,000 Added 2.53%	1,299,100 $105 Million
Q3 2023 Nov 09, 2023	BUY	$73.94 - $80.67 $15.5 Million - $16.9 Million	209,800 Added 19.84%	1,267,100 $95 Million
Q2 2023 Aug 11, 2023	SELL	$76.01 - $86.7 $25.3 Million - $28.8 Million	-332,200 Reduced 23.91%	1,057,300 $81.5 Million
Q1 2023 May 12, 2023	SELL	$77.31 - $88.08 $41 Million - $46.7 Million	-529,845 Reduced 27.61%	1,389,500 $115 Million
Q4 2022 Feb 08, 2023	BUY	$62.32 - $89.47 $50.5 Million - $72.5 Million	810,145 Added 73.04%	1,919,345 $165 Million
Q3 2022 Nov 10, 2022	BUY	$59.54 - $68.01 $13.3 Million - $15.2 Million	223,400 Added 25.22%	1,109,200 $68.4 Million
Q2 2022 Aug 10, 2022	SELL	$57.72 - $65.01 $30.5 Million - $34.4 Million	-529,100 Reduced 37.39%	885,800 $54.8 Million
Q1 2022 May 16, 2022	SELL	$57.92 - $72.58 $29.1 Million - $36.4 Million	-502,200 Reduced 26.2%	1,414,900 $84.1 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $24.8 Million - $28.1 Million	381,481 Added 24.84%	1,917,100 $139 Million
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $45.2 Million - $48.8 Million	668,011 Added 76.99%	1,535,619 $107 Million
Q2 2021 Aug 13, 2021	SELL	$63.47 - $69.35 $29.2 Million - $31.9 Million	-460,418 Reduced 34.67%	867,608 $59.7 Million
Q1 2021 May 12, 2021	BUY	$60.0 - $68.46 $15.9 Million - $18.1 Million	264,626 Added 24.88%	1,328,026 $85.8 Million
Q4 2020 Feb 11, 2021	BUY	$56.65 - $64.55 $15.3 Million - $17.4 Million	270,100 Added 34.05%	1,063,400 $62 Million
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $2.12 Million - $2.66 Million	-34,100 Reduced 4.12%	793,300 $50.1 Million
Q2 2020 Jul 31, 2020	SELL	$72.34 - $84.0 $28.6 Million - $33.2 Million	-395,200 Reduced 32.32%	827,400 $63.7 Million
Q1 2020 May 01, 2020	BUY	$62.63 - $80.22 $26.5 Million - $34 Million	423,300 Added 52.96%	1,222,600 $91.4 Million
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $2.06 Million - $2.27 Million	33,500 Added 4.37%	799,300 $51.9 Million
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $11.2 Million - $12.4 Million	179,000 Added 30.5%	765,800 $48.5 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $7.3 Million - $8.19 Million	-118,000 Reduced 16.74%	586,800 $39.6 Million
Q1 2019 May 14, 2019	SELL	$62.53 - $70.05 $45 Million - $50.4 Million	-719,700 Reduced 50.52%	704,800 $45.8 Million
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $43.8 Million - $57.1 Million	-723,300 Reduced 33.68%	1,424,500 $89.1 Million
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $12.9 Million - $14.2 Million	-180,300 Reduced 7.74%	2,147,800 $166 Million
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $36.2 Million - $42.2 Million	558,200 Added 31.54%	2,328,100 $165 Million
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $16 Million - $19.5 Million	-219,900 Reduced 11.05%	1,769,900 $133 Million
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $14.6 Million - $17.2 Million	205,600 Added 11.52%	1,989,800 $143 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $15.3 Million - $18.1 Million	211,700 Added 13.46%	1,784,200 $145 Million
Q2 2017 Aug 14, 2017	SELL	N/A	-223,600 Reduced 12.45%	1,572,500 $111 Million
Q1 2017 Nov 14, 2017	BUY	N/A	1,796,100	1,796,100 $122 Million

Others Institutions Holding GILD

# of Institutions

1,931

Shares Held

991M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$10.8 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.3 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$6.82 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.51 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.36 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $112B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account